Celltrion Pharm Inc (068760) — Cash Flow Reinvestment Rate
Celltrion Pharm Inc (068760) has a Cash Flow Reinvestment Rate of 0.95x as of September 2025, reinvesting ₩22.17 Billion (capex ₩2.27 Billion plus investments ₩-19.90 Billion) from operating cash flow of ₩23.44 Billion. Check Celltrion Pharm Inc (068760) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Celltrion Pharm Inc Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for Celltrion Pharm Inc across 8 annual periods. Explore 068760 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Celltrion Pharm Inc (2014–2024)
Year-by-year capital reinvestment analysis for Celltrion Pharm Inc. For live market cap and broader valuation context, see market cap of Celltrion Pharm Inc.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.32x | ₩18.10 Billion | ₩56.59 Billion | ₩5.98 Billion | ▼ -74.8% |
| 2023 | 1.27x | ₩11.12 Billion | ₩8.76 Billion | ₩6.90 Billion | ▲ +310.6% |
| 2021 | 0.31x | ₩28.81 Billion | ₩93.15 Billion | ₩12.50 Billion | ▼ -73.7% |
| 2020 | 1.18x | ₩42.61 Billion | ₩36.25 Billion | ₩41.98 Billion | ▼ -0.9% |
| 2019 | 1.19x | ₩33.06 Billion | ₩27.85 Billion | ₩30.49 Billion | ▲ +125.8% |
| 2018 | 0.53x | ₩7.52 Billion | ₩14.31 Billion | ₩7.21 Billion | ▼ -85.2% |
| 2015 | 3.55x | ₩47.38 Billion | ₩13.36 Billion | ₩45.97 Billion | ▲ +131.5% |
| 2014 | 1.53x | ₩26.53 Billion | ₩17.33 Billion | ₩26.16 Billion | — |